glp-1-based therapy GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies GLP-1 Receptor Agonists for Obesity

While it is not known if the impact on blood pressure was due to the medication or the participants weight loss, the lower blood pressure measures seen with tirzepatide rivaled what is seen for many hypertension medications, lead study author Dr

With the International Testing Agency (ITA) overseeing anti-doping operations at Milano Cortina 2026, the scrutiny on supplement use has intensified

The gold-standard for diagnosing gout is identification of intracellular monosodium urate crystals with polarising light microscopy in aspirated fluid from the affected joint

The report covers the Middle East And Africa Glucagon-like Peptide-1 Agonists Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024